# Improving trial generalizability using observational studies

arXiv: https://arxiv.org/abs/2003.01242 · HTML: https://mlsanity.com/paper/2003.01242/

## Key facts

- Cited by 7 papers in the map (data through 14 Oct 2026).
- First posted on arXiv 2 Mar 2020.

## Built on by (most cited first, 7 of 7)

- [Combining Experimental and Historical Data for Policy Evaluation](https://mlsanity.com/paper/2406.00317/) (2024)
- [Efficient and robust transfer learning of optimal individualized treatment regimes with right-censored survival data](https://mlsanity.com/paper/2301.05491/) (2023)
- [Targeted Optimal Treatment Regime Learning Using Summary Statistics](https://mlsanity.com/paper/2201.06229/) (2022)
- [Causal Customer Churn Analysis with Low-rank Tensor Block Hazard Model](https://mlsanity.com/paper/2405.11377/) (2024)
- [Doubly Robust Fusion of Many Treatments for Policy Learning](https://mlsanity.com/paper/2505.08092/) (2025)
- [Rate doubly robust estimation for weighted average treatment effects](https://mlsanity.com/paper/2509.14502/) (2025)
- [Integrating RCTs, RWD, AI/ML and Statistics: Next-Generation Evidence Synthesis](https://mlsanity.com/paper/2511.19735/) (2025)

## Abstract (arXiv)

Complementary features of randomized controlled trials (RCTs) and observational studies (OSs) can be used jointly to estimate the average treatment effect of a target population. We propose a calibration weighting estimator that enforces the covariate balance between the RCT and OS, therefore improving the trial-based estimator's generalizability. Exploiting semiparametric efficiency theory, we propose a doubly robust augmented calibration weighting estimator that achieves the efficiency bound derived under the identification assumptions. A nonparametric sieve method is provided as an alternative to the parametric approach, which enables the robust approximation of the nuisance functions and data-adaptive selection of outcome predictors for calibration. We establish asymptotic results and confirm the finite sample performances of the proposed estimators by simulation experiments and an application on the estimation of the treatment effect of adjuvant chemotherapy for early-stage non-small cell lung patients after surgery.